Open10.850 | Close- |
Vol / Avg.1.728M / 5.408M | Mkt Cap5.171B |
Day Range10.425 - 10.860 | 52 Wk Range7.880 - 14.690 |
Elanco Animal Health Stock (NYSE: ELAN) stock price, news, charts, stock research, profile.
Open10.850 | Close- |
Vol / Avg.1.728M / 5.408M | Mkt Cap5.171B |
Day Range10.425 - 10.860 | 52 Wk Range7.880 - 14.690 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 0.050 | 0.180 | 0.1300 | ||||
REV | 1.036B | 1.057B | 21.000M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-14 | Piper Sandler | David Westenberg | Maintains | NeutralNeutral | Raises | 9.00 | 13.00 |
2023-08-09 | Goldman Sachs | Nathan Rich | Maintains | SellSell | Raises | 8.50 | 9.50 |
2023-08-08 | Goldman Sachs | Nathan Rich | Maintains | SellSell | Raises | 8.50 | 9.50 |
2023-04-26 | Goldman Sachs | Nathan Rich | Maintains | Sell | Lowers | 10.50 | 9.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
ELAN | Elanco Animal Health | -4.24% | 5.2B |
NVO | Novo Nordisk | -4.89% | 390.5B |
JNJ | Johnson & Johnson | -0.29% | 372.5B |
MRK | Merck & Co | -1.3% | 256.8B |
NVS | Novartis | -1.7% | 206.4B |
You can purchase shares of Elanco Animal Health (NYSE: ELAN) through any online brokerage.
Other companies in Elanco Animal Health’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Novartis (NYSE:NVS) and Pfizer (NYSE:PFE).
The latest price target for Elanco Animal Health (NYSE: ELAN) was reported by Piper Sandler on Monday, August 14, 2023. The analyst firm set a price target for 13.00 expecting ELAN to rise to within 12 months (a possible 23.87% upside). 13 analyst firms have reported ratings in the last year.
The stock price for Elanco Animal Health (NYSE: ELAN) is $10.495 last updated Today at October 3, 2023 at 4:37 PM UTC.
There is no dividend information for Elanco Animal Health.
Elanco Animal Health’s Q3 earnings are confirmed for Tuesday, November 7, 2023.
There is no upcoming split for Elanco Animal Health.
Elanco Animal Health is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.
Elanco Animal Health Stock (NYSE: ELAN) stock price, news, charts, stock research, profile.
Open10.850 | Close- |
Vol / Avg.1.728M / 5.408M | Mkt Cap5.171B |
Day Range10.425 - 10.860 | 52 Wk Range7.880 - 14.690 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 0.050 | 0.180 | 0.1300 | ||||
REV | 1.036B | 1.057B | 21.000M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-14 | Piper Sandler | David Westenberg | Maintains | NeutralNeutral | Raises | 9.00 | 13.00 |
2023-08-09 | Goldman Sachs | Nathan Rich | Maintains | SellSell | Raises | 8.50 | 9.50 |
2023-08-08 | Goldman Sachs | Nathan Rich | Maintains | SellSell | Raises | 8.50 | 9.50 |
2023-04-26 | Goldman Sachs | Nathan Rich | Maintains | Sell | Lowers | 10.50 | 9.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
ELAN | Elanco Animal Health | -4.24% | 5.2B |
NVO | Novo Nordisk | -4.89% | 390.5B |
JNJ | Johnson & Johnson | -0.29% | 372.5B |
MRK | Merck & Co | -1.3% | 256.8B |
NVS | Novartis | -1.7% | 206.4B |
You can purchase shares of Elanco Animal Health (NYSE: ELAN) through any online brokerage.
Other companies in Elanco Animal Health’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Novartis (NYSE:NVS) and Pfizer (NYSE:PFE).
The latest price target for Elanco Animal Health (NYSE: ELAN) was reported by Piper Sandler on Monday, August 14, 2023. The analyst firm set a price target for 13.00 expecting ELAN to rise to within 12 months (a possible 23.87% upside). 13 analyst firms have reported ratings in the last year.
The stock price for Elanco Animal Health (NYSE: ELAN) is $10.495 last updated Today at October 3, 2023 at 4:37 PM UTC.
There is no dividend information for Elanco Animal Health.
Elanco Animal Health’s Q3 earnings are confirmed for Tuesday, November 7, 2023.
There is no upcoming split for Elanco Animal Health.
Elanco Animal Health is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.
Elanco Animal Health Stock (NYSE: ELAN) stock price, news, charts, stock research, profile.
Open10.850 | Close- |
Vol / Avg.1.728M / 5.408M | Mkt Cap5.171B |
Day Range10.425 - 10.860 | 52 Wk Range7.880 - 14.690 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 0.050 | 0.180 | 0.1300 | ||||
REV | 1.036B | 1.057B | 21.000M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-14 | Piper Sandler | David Westenberg | Maintains | NeutralNeutral | Raises | 9.00 | 13.00 |
2023-08-09 | Goldman Sachs | Nathan Rich | Maintains | SellSell | Raises | 8.50 | 9.50 |
2023-08-08 | Goldman Sachs | Nathan Rich | Maintains | SellSell | Raises | 8.50 | 9.50 |
2023-04-26 | Goldman Sachs | Nathan Rich | Maintains | Sell | Lowers | 10.50 | 9.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
ELAN | Elanco Animal Health | -4.24% | 5.2B |
NVO | Novo Nordisk | -4.89% | 390.5B |
JNJ | Johnson & Johnson | -0.29% | 372.5B |
MRK | Merck & Co | -1.3% | 256.8B |
NVS | Novartis | -1.7% | 206.4B |
You can purchase shares of Elanco Animal Health (NYSE: ELAN) through any online brokerage.
Other companies in Elanco Animal Health’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Novartis (NYSE:NVS) and Pfizer (NYSE:PFE).
The latest price target for Elanco Animal Health (NYSE: ELAN) was reported by Piper Sandler on Monday, August 14, 2023. The analyst firm set a price target for 13.00 expecting ELAN to rise to within 12 months (a possible 23.87% upside). 13 analyst firms have reported ratings in the last year.
The stock price for Elanco Animal Health (NYSE: ELAN) is $10.495 last updated Today at October 3, 2023 at 4:37 PM UTC.
There is no dividend information for Elanco Animal Health.
Elanco Animal Health’s Q3 earnings are confirmed for Tuesday, November 7, 2023.
There is no upcoming split for Elanco Animal Health.
Elanco Animal Health is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.
Elanco Animal Health Stock (NYSE: ELAN) stock price, news, charts, stock research, profile.
Open10.850 | Close- |
Vol / Avg.1.728M / 5.408M | Mkt Cap5.171B |
Day Range10.425 - 10.860 | 52 Wk Range7.880 - 14.690 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 0.050 | 0.180 | 0.1300 | ||||
REV | 1.036B | 1.057B | 21.000M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-14 | Piper Sandler | David Westenberg | Maintains | NeutralNeutral | Raises | 9.00 | 13.00 |
2023-08-09 | Goldman Sachs | Nathan Rich | Maintains | SellSell | Raises | 8.50 | 9.50 |
2023-08-08 | Goldman Sachs | Nathan Rich | Maintains | SellSell | Raises | 8.50 | 9.50 |
2023-04-26 | Goldman Sachs | Nathan Rich | Maintains | Sell | Lowers | 10.50 | 9.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
ELAN | Elanco Animal Health | -4.24% | 5.2B |
NVO | Novo Nordisk | -4.89% | 390.5B |
JNJ | Johnson & Johnson | -0.29% | 372.5B |
MRK | Merck & Co | -1.3% | 256.8B |
NVS | Novartis | -1.7% | 206.4B |
You can purchase shares of Elanco Animal Health (NYSE: ELAN) through any online brokerage.
Other companies in Elanco Animal Health’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Novartis (NYSE:NVS) and Pfizer (NYSE:PFE).
The latest price target for Elanco Animal Health (NYSE: ELAN) was reported by Piper Sandler on Monday, August 14, 2023. The analyst firm set a price target for 13.00 expecting ELAN to rise to within 12 months (a possible 23.87% upside). 13 analyst firms have reported ratings in the last year.
The stock price for Elanco Animal Health (NYSE: ELAN) is $10.495 last updated Today at October 3, 2023 at 4:37 PM UTC.
There is no dividend information for Elanco Animal Health.
Elanco Animal Health’s Q3 earnings are confirmed for Tuesday, November 7, 2023.
There is no upcoming split for Elanco Animal Health.
Elanco Animal Health is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.
Elanco Animal Health Stock (NYSE: ELAN) stock price, news, charts, stock research, profile.
Open10.850 | Close- |
Vol / Avg.1.728M / 5.408M | Mkt Cap5.171B |
Day Range10.425 - 10.860 | 52 Wk Range7.880 - 14.690 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 0.050 | 0.180 | 0.1300 | ||||
REV | 1.036B | 1.057B | 21.000M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-14 | Piper Sandler | David Westenberg | Maintains | NeutralNeutral | Raises | 9.00 | 13.00 |
2023-08-09 | Goldman Sachs | Nathan Rich | Maintains | SellSell | Raises | 8.50 | 9.50 |
2023-08-08 | Goldman Sachs | Nathan Rich | Maintains | SellSell | Raises | 8.50 | 9.50 |
2023-04-26 | Goldman Sachs | Nathan Rich | Maintains | Sell | Lowers | 10.50 | 9.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
ELAN | Elanco Animal Health | -4.24% | 5.2B |
NVO | Novo Nordisk | -4.89% | 390.5B |
JNJ | Johnson & Johnson | -0.29% | 372.5B |
MRK | Merck & Co | -1.3% | 256.8B |
NVS | Novartis | -1.7% | 206.4B |
You can purchase shares of Elanco Animal Health (NYSE: ELAN) through any online brokerage.
Other companies in Elanco Animal Health’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Novartis (NYSE:NVS) and Pfizer (NYSE:PFE).
The latest price target for Elanco Animal Health (NYSE: ELAN) was reported by Piper Sandler on Monday, August 14, 2023. The analyst firm set a price target for 13.00 expecting ELAN to rise to within 12 months (a possible 23.87% upside). 13 analyst firms have reported ratings in the last year.
The stock price for Elanco Animal Health (NYSE: ELAN) is $10.495 last updated Today at October 3, 2023 at 4:37 PM UTC.
There is no dividend information for Elanco Animal Health.
Elanco Animal Health’s Q3 earnings are confirmed for Tuesday, November 7, 2023.
There is no upcoming split for Elanco Animal Health.
Elanco Animal Health is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.
Elanco Animal Health Stock (NYSE: ELAN) stock price, news, charts, stock research, profile.
Open10.850 | Close- |
Vol / Avg.1.728M / 5.408M | Mkt Cap5.171B |
Day Range10.425 - 10.860 | 52 Wk Range7.880 - 14.690 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 0.050 | 0.180 | 0.1300 | ||||
REV | 1.036B | 1.057B | 21.000M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-14 | Piper Sandler | David Westenberg | Maintains | NeutralNeutral | Raises | 9.00 | 13.00 |
2023-08-09 | Goldman Sachs | Nathan Rich | Maintains | SellSell | Raises | 8.50 | 9.50 |
2023-08-08 | Goldman Sachs | Nathan Rich | Maintains | SellSell | Raises | 8.50 | 9.50 |
2023-04-26 | Goldman Sachs | Nathan Rich | Maintains | Sell | Lowers | 10.50 | 9.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
ELAN | Elanco Animal Health | -4.24% | 5.2B |
NVO | Novo Nordisk | -4.89% | 390.5B |
JNJ | Johnson & Johnson | -0.29% | 372.5B |
MRK | Merck & Co | -1.3% | 256.8B |
NVS | Novartis | -1.7% | 206.4B |
You can purchase shares of Elanco Animal Health (NYSE: ELAN) through any online brokerage.
Other companies in Elanco Animal Health’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Novartis (NYSE:NVS) and Pfizer (NYSE:PFE).
The latest price target for Elanco Animal Health (NYSE: ELAN) was reported by Piper Sandler on Monday, August 14, 2023. The analyst firm set a price target for 13.00 expecting ELAN to rise to within 12 months (a possible 23.87% upside). 13 analyst firms have reported ratings in the last year.
The stock price for Elanco Animal Health (NYSE: ELAN) is $10.495 last updated Today at October 3, 2023 at 4:37 PM UTC.
There is no dividend information for Elanco Animal Health.
Elanco Animal Health’s Q3 earnings are confirmed for Tuesday, November 7, 2023.
There is no upcoming split for Elanco Animal Health.
Elanco Animal Health is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.
Elanco Animal Health Stock (NYSE: ELAN) stock price, news, charts, stock research, profile.
Open10.850 | Close- |
Vol / Avg.1.728M / 5.408M | Mkt Cap5.171B |
Day Range10.425 - 10.860 | 52 Wk Range7.880 - 14.690 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 0.050 | 0.180 | 0.1300 | ||||
REV | 1.036B | 1.057B | 21.000M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-14 | Piper Sandler | David Westenberg | Maintains | NeutralNeutral | Raises | 9.00 | 13.00 |
2023-08-09 | Goldman Sachs | Nathan Rich | Maintains | SellSell | Raises | 8.50 | 9.50 |
2023-08-08 | Goldman Sachs | Nathan Rich | Maintains | SellSell | Raises | 8.50 | 9.50 |
2023-04-26 | Goldman Sachs | Nathan Rich | Maintains | Sell | Lowers | 10.50 | 9.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
ELAN | Elanco Animal Health | -4.24% | 5.2B |
NVO | Novo Nordisk | -4.89% | 390.5B |
JNJ | Johnson & Johnson | -0.29% | 372.5B |
MRK | Merck & Co | -1.3% | 256.8B |
NVS | Novartis | -1.7% | 206.4B |
You can purchase shares of Elanco Animal Health (NYSE: ELAN) through any online brokerage.
Other companies in Elanco Animal Health’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Novartis (NYSE:NVS) and Pfizer (NYSE:PFE).
The latest price target for Elanco Animal Health (NYSE: ELAN) was reported by Piper Sandler on Monday, August 14, 2023. The analyst firm set a price target for 13.00 expecting ELAN to rise to within 12 months (a possible 23.87% upside). 13 analyst firms have reported ratings in the last year.
The stock price for Elanco Animal Health (NYSE: ELAN) is $10.495 last updated Today at October 3, 2023 at 4:37 PM UTC.
There is no dividend information for Elanco Animal Health.
Elanco Animal Health’s Q3 earnings are confirmed for Tuesday, November 7, 2023.
There is no upcoming split for Elanco Animal Health.
Elanco Animal Health is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.
Elanco Animal Health Stock (NYSE: ELAN) stock price, news, charts, stock research, profile.
Open10.850 | Close- |
Vol / Avg.1.728M / 5.408M | Mkt Cap5.171B |
Day Range10.425 - 10.860 | 52 Wk Range7.880 - 14.690 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 0.050 | 0.180 | 0.1300 | ||||
REV | 1.036B | 1.057B | 21.000M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-14 | Piper Sandler | David Westenberg | Maintains | NeutralNeutral | Raises | 9.00 | 13.00 |
2023-08-09 | Goldman Sachs | Nathan Rich | Maintains | SellSell | Raises | 8.50 | 9.50 |
2023-08-08 | Goldman Sachs | Nathan Rich | Maintains | SellSell | Raises | 8.50 | 9.50 |
2023-04-26 | Goldman Sachs | Nathan Rich | Maintains | Sell | Lowers | 10.50 | 9.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
ELAN | Elanco Animal Health | -4.24% | 5.2B |
NVO | Novo Nordisk | -4.89% | 390.5B |
JNJ | Johnson & Johnson | -0.29% | 372.5B |
MRK | Merck & Co | -1.3% | 256.8B |
NVS | Novartis | -1.7% | 206.4B |
You can purchase shares of Elanco Animal Health (NYSE: ELAN) through any online brokerage.
Other companies in Elanco Animal Health’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Novartis (NYSE:NVS) and Pfizer (NYSE:PFE).
The latest price target for Elanco Animal Health (NYSE: ELAN) was reported by Piper Sandler on Monday, August 14, 2023. The analyst firm set a price target for 13.00 expecting ELAN to rise to within 12 months (a possible 23.87% upside). 13 analyst firms have reported ratings in the last year.
The stock price for Elanco Animal Health (NYSE: ELAN) is $10.495 last updated Today at October 3, 2023 at 4:37 PM UTC.
There is no dividend information for Elanco Animal Health.
Elanco Animal Health’s Q3 earnings are confirmed for Tuesday, November 7, 2023.
There is no upcoming split for Elanco Animal Health.
Elanco Animal Health is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.
Elanco Animal Health Stock (NYSE: ELAN) stock price, news, charts, stock research, profile.
Open10.850 | Close- |
Vol / Avg.1.728M / 5.408M | Mkt Cap5.171B |
Day Range10.425 - 10.860 | 52 Wk Range7.880 - 14.690 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 0.050 | 0.180 | 0.1300 | ||||
REV | 1.036B | 1.057B | 21.000M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-14 | Piper Sandler | David Westenberg | Maintains | NeutralNeutral | Raises | 9.00 | 13.00 |
2023-08-09 | Goldman Sachs | Nathan Rich | Maintains | SellSell | Raises | 8.50 | 9.50 |
2023-08-08 | Goldman Sachs | Nathan Rich | Maintains | SellSell | Raises | 8.50 | 9.50 |
2023-04-26 | Goldman Sachs | Nathan Rich | Maintains | Sell | Lowers | 10.50 | 9.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
ELAN | Elanco Animal Health | -4.24% | 5.2B |
NVO | Novo Nordisk | -4.89% | 390.5B |
JNJ | Johnson & Johnson | -0.29% | 372.5B |
MRK | Merck & Co | -1.3% | 256.8B |
NVS | Novartis | -1.7% | 206.4B |
You can purchase shares of Elanco Animal Health (NYSE: ELAN) through any online brokerage.
Other companies in Elanco Animal Health’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Novartis (NYSE:NVS) and Pfizer (NYSE:PFE).
The latest price target for Elanco Animal Health (NYSE: ELAN) was reported by Piper Sandler on Monday, August 14, 2023. The analyst firm set a price target for 13.00 expecting ELAN to rise to within 12 months (a possible 23.87% upside). 13 analyst firms have reported ratings in the last year.
The stock price for Elanco Animal Health (NYSE: ELAN) is $10.495 last updated Today at October 3, 2023 at 4:37 PM UTC.
There is no dividend information for Elanco Animal Health.
Elanco Animal Health’s Q3 earnings are confirmed for Tuesday, November 7, 2023.
There is no upcoming split for Elanco Animal Health.
Elanco Animal Health is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.